Fractyl Health Q4 Earnings Call Highlights [Yahoo! Finance]
Fractyl Health, Inc. (GUTS)
Company Research
Source: Yahoo! Finance
New analyses show treatment “dose” — specifically ablation length — drives efficacy, with clear benefit at =16 centimeters ; in patients with 17.5% run-in weight loss Revita cut 6-month post-GLP-1 weight regain by ~70% (2.9% vs 9.9%) and preserved ~88% of tirzepatide-associated loss versus ~60% for sham. The pivotal REMAIN-1 trial has 300 patients across 30 U.S. sites, is powered 90% with mean run-in loss 18.3% and mean ablation 16 cm, and the company expects top-line 6-month pivotal data in early Q4 2026 and one-year midpoint randomized data in Q3 2026. Fractyl received favorable FDA feedback on a de novo pathway and plans de novo submission in late Q4 2026 and a Category III CPT filing in June 2026; the company has about $81.5M cash (plus $4.1M in Jan 2026), providing a cash runway into early 2027 and no planned capital raise before pivotal readout. Interested in Fractyl Health, Inc.? Here are five stocks we like better. Fractyl Health (NASDAQ:GUTS) used its fourth-quarter
Show less
Read more
Impact Snapshot
Event Time:
GUTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GUTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GUTS alerts
High impacting Fractyl Health, Inc. news events
Weekly update
A roundup of the hottest topics
GUTS
News
- Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesGlobeNewswire
- H.C. Wainwright Maintains a Buy Rating on Fractyl Health, Inc. (GUTS) with an $8 Price Target [Yahoo! Finance]Yahoo! Finance
- Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 [Yahoo! Finance]Yahoo! Finance
- Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026GlobeNewswire
- Fractyl Health, Inc. (GUTS) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]Yahoo! Finance
GUTS
Sec Filings
- 3/24/26 - Form 10-K
- 3/24/26 - Form 8-K
- 3/17/26 - Form 8-K
- GUTS's page on the SEC website